Revealing anti-inflammatory mechanisms of soy isoflavones by flow: modulation of leukocyte-endothelial cell interactions

Departments of 1 Pathology, 2 Pharmacology, and 3 Anesthesiology, 4 Purdue-University of Alabama at Birmingham Botanical Center for Age-Related Disease, and 5 Center for Free Radical Biology, University of Alabama at Birmingham; and 6 Research Service, Birmingham Veterans Affairs Medical Center, Bir...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of physiology. Heart and circulatory physiology Vol. 289; no. 2; pp. H908 - H915
Main Authors Chacko, Balu K, Chandler, Robert T, Mundhekar, Ameya, Khoo, Nicholas, Pruitt, Heather M, Kucik, Dennis F, Parks, Dale A, Kevil, Christopher G, Barnes, Stephen, Patel, Rakesh P
Format Journal Article
LanguageEnglish
Published United States 01.08.2005
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Departments of 1 Pathology, 2 Pharmacology, and 3 Anesthesiology, 4 Purdue-University of Alabama at Birmingham Botanical Center for Age-Related Disease, and 5 Center for Free Radical Biology, University of Alabama at Birmingham; and 6 Research Service, Birmingham Veterans Affairs Medical Center, Birmingham, Alabama; and 7 Department of Pathology, Louisiana State University, Shreveport, Louisiana Submitted 2 August 2004 ; accepted in final form 28 March 2005 The antiatherogenic effects of soy isoflavone consumption have been demonstrated in a variety of studies. However, the mechanisms involved remain poorly defined. Adhesion of monocytes to vascular endothelial cells is a key step within the inflammatory cascade that leads to atherogenesis. Many factors, including the physical forces associated with blood flow, regulate this process. Using an in vitro flow assay, we report that genistein, a principal component of most isoflavone preparations, inhibits monocyte adhesion to cytokine (TNF- )-stimulated human vascular endothelial cells at physiologically relevant concentrations (0–1 µM). This effect is absolutely dependent on flow and is not observed under static conditions. Furthermore, this inhibition was dependent on activation of endothelial peroxisomal proliferator-activated receptor- . No significant role for other reported properties of genistein, including antioxidant effects, inhibition of tyrosine kinases, or activation of estrogen receptors, was observed. Furthermore, the antiadhesive effects of genistein did not occur via modulation of the adhesion molecules E-selectin, ICAM-1, VCAM-1, or platelet-endothelial cell adhesion molecule-1. These data reveal a novel anti-inflammatory mechanism for isoflavones and identify the physical forces associated with blood flow and a critical mediator of this function. inflammation; genistein; peroxisomal proliferator-activated receptor- ; atherosclerosis; monocytes Address for reprint requests and other correspondence: R. P. Patel, Dept. of Pathology, Univ. of Alabama at Birmingham, 901 19th St. South, BMR-2, Rm. 307, Birmingham, AL 35294 (E-mail: patel{at}path.uab.edu )
AbstractList The antiatherogenic effects of soy isoflavone consumption have been demonstrated in a variety of studies. However, the mechanisms involved remain poorly defined. Adhesion of monocytes to vascular endothelial cells is a key step within the inflammatory cascade that leads to atherogenesis. Many factors, including the physical forces associated with blood flow, regulate this process. Using an in vitro flow assay, we report that genistein, a principal component of most isoflavone preparations, inhibits monocyte adhesion to cytokine (TNF-alpha)-stimulated human vascular endothelial cells at physiologically relevant concentrations (0-1 microM). This effect is absolutely dependent on flow and is not observed under static conditions. Furthermore, this inhibition was dependent on activation of endothelial peroxisomal proliferator-activated receptor-gamma. No significant role for other reported properties of genistein, including antioxidant effects, inhibition of tyrosine kinases, or activation of estrogen receptors, was observed. Furthermore, the antiadhesive effects of genistein did not occur via modulation of the adhesion molecules E-selectin, ICAM-1, VCAM-1, or platelet-endothelial cell adhesion molecule-1. These data reveal a novel anti-inflammatory mechanism for isoflavones and identify the physical forces associated with blood flow and a critical mediator of this function.
The antiatherogenic effects of soy isoflavone consumption have been demonstrated in a variety of studies. However, the mechanisms involved remain poorly defined. Adhesion of monocytes to vascular endothelial cells is a key step within the inflammatory cascade that leads to atherogenesis. Many factors, including the physical forces associated with blood flow, regulate this process. Using an in vitro flow assay, we report that genistein, a principal component of most isoflavone preparations, inhibits monocyte adhesion to cytokine (TNF-α)-stimulated human vascular endothelial cells at physiologically relevant concentrations (0–1 μM). This effect is absolutely dependent on flow and is not observed under static conditions. Furthermore, this inhibition was dependent on activation of endothelial peroxisomal proliferator-activated receptor-γ. No significant role for other reported properties of genistein, including antioxidant effects, inhibition of tyrosine kinases, or activation of estrogen receptors, was observed. Furthermore, the antiadhesive effects of genistein did not occur via modulation of the adhesion molecules E-selectin, ICAM-1, VCAM-1, or platelet-endothelial cell adhesion molecule-1. These data reveal a novel anti-inflammatory mechanism for isoflavones and identify the physical forces associated with blood flow and a critical mediator of this function.
Departments of 1 Pathology, 2 Pharmacology, and 3 Anesthesiology, 4 Purdue-University of Alabama at Birmingham Botanical Center for Age-Related Disease, and 5 Center for Free Radical Biology, University of Alabama at Birmingham; and 6 Research Service, Birmingham Veterans Affairs Medical Center, Birmingham, Alabama; and 7 Department of Pathology, Louisiana State University, Shreveport, Louisiana Submitted 2 August 2004 ; accepted in final form 28 March 2005 The antiatherogenic effects of soy isoflavone consumption have been demonstrated in a variety of studies. However, the mechanisms involved remain poorly defined. Adhesion of monocytes to vascular endothelial cells is a key step within the inflammatory cascade that leads to atherogenesis. Many factors, including the physical forces associated with blood flow, regulate this process. Using an in vitro flow assay, we report that genistein, a principal component of most isoflavone preparations, inhibits monocyte adhesion to cytokine (TNF- )-stimulated human vascular endothelial cells at physiologically relevant concentrations (0–1 µM). This effect is absolutely dependent on flow and is not observed under static conditions. Furthermore, this inhibition was dependent on activation of endothelial peroxisomal proliferator-activated receptor- . No significant role for other reported properties of genistein, including antioxidant effects, inhibition of tyrosine kinases, or activation of estrogen receptors, was observed. Furthermore, the antiadhesive effects of genistein did not occur via modulation of the adhesion molecules E-selectin, ICAM-1, VCAM-1, or platelet-endothelial cell adhesion molecule-1. These data reveal a novel anti-inflammatory mechanism for isoflavones and identify the physical forces associated with blood flow and a critical mediator of this function. inflammation; genistein; peroxisomal proliferator-activated receptor- ; atherosclerosis; monocytes Address for reprint requests and other correspondence: R. P. Patel, Dept. of Pathology, Univ. of Alabama at Birmingham, 901 19th St. South, BMR-2, Rm. 307, Birmingham, AL 35294 (E-mail: patel{at}path.uab.edu )
Author Parks, Dale A
Chandler, Robert T
Chacko, Balu K
Khoo, Nicholas
Pruitt, Heather M
Kucik, Dennis F
Barnes, Stephen
Patel, Rakesh P
Mundhekar, Ameya
Kevil, Christopher G
Author_xml – sequence: 1
  fullname: Chacko, Balu K
– sequence: 2
  fullname: Chandler, Robert T
– sequence: 3
  fullname: Mundhekar, Ameya
– sequence: 4
  fullname: Khoo, Nicholas
– sequence: 5
  fullname: Pruitt, Heather M
– sequence: 6
  fullname: Kucik, Dennis F
– sequence: 7
  fullname: Parks, Dale A
– sequence: 8
  fullname: Kevil, Christopher G
– sequence: 9
  fullname: Barnes, Stephen
– sequence: 10
  fullname: Patel, Rakesh P
BackLink https://www.ncbi.nlm.nih.gov/pubmed/15805228$$D View this record in MEDLINE/PubMed
BookMark eNp1kMtO5DAQRS3EaGiY-QIk5B9IY8d5OOxGaHhISEgjZm05drljcOwodkPn70loHitWtahzr67OMTr0wQNCp5SsKS3zc_k4dCDHtCak5nSdE1IcoNX8yTNasuYQrQirWFZRVh6h4xgfCSFlXbGf6IiWnMwcX6HdP3gG6azfYOmTzaw3Tva9TGGccA-qk97GPuJgcAwTtjHM_-d5SMTthI0LLxe4D3rrZLLBL5iD7VNQU4IMvA6pA2elwwqcw9YnGKVayPgL_TDSRfj9fk_Q_6u_D5c32d399e3ln7tMsYalDIrC1DUHSqrS8IJxqSrNCYDWDSctK2QpeZ2TtpCaGM2qMm9VM_tQM9dyw04Q2_eqMcQ4ghHDaHs5ToISsXgUHx7Fm0exeJxTZ_vUsG170F-Zd3EzcLEHOrvpXuwIYuimaIMLm0lcbZ17gF36rM55I3Jx0xAuBr1sWn8f_pzzFWKvug2chQ
CitedBy_id crossref_primary_10_1097_JTO_0000000000000677
crossref_primary_10_3390_fib12040031
crossref_primary_10_1007_s10495_008_0283_9
crossref_primary_10_3945_jn_109_120626
crossref_primary_10_1007_s00394_013_0509_7
crossref_primary_10_1177_2156587215595146
crossref_primary_10_1016_j_brainres_2019_146434
crossref_primary_10_1016_j_jnutbio_2009_09_002
crossref_primary_10_1093_jn_136_9_2384
crossref_primary_10_3390_ijms17081318
crossref_primary_10_1002_mabi_202100114
crossref_primary_10_1007_s11101_015_9398_0
crossref_primary_10_1093_ndt_gfl169
crossref_primary_10_1016_j_nutres_2009_09_002
crossref_primary_10_1080_00397911_2020_1792932
crossref_primary_10_1097_HJH_0b013e32835c0905
crossref_primary_10_1017_S0007114511002571
crossref_primary_10_1016_j_tet_2021_132573
crossref_primary_10_1016_j_heliyon_2023_e13352
crossref_primary_10_1111_j_1467_789X_2008_00554_x
crossref_primary_10_13005_bbra_2986
crossref_primary_10_1016_j_aninu_2023_12_005
crossref_primary_10_1016_j_jss_2009_04_048
crossref_primary_10_1007_s00394_012_0331_7
crossref_primary_10_4236_fns_2013_48A002
crossref_primary_10_1074_jbc_M111_247981
crossref_primary_10_1111_j_1467_789X_2009_00644_x
crossref_primary_10_1016_j_cyto_2008_06_016
crossref_primary_10_1093_jn_138_2_332
crossref_primary_10_31393_reports_vnmedical_2023_27_4__26
crossref_primary_10_1002_adhm_201701175
crossref_primary_10_1016_j_clnu_2018_09_007
crossref_primary_10_1016_j_neuint_2012_04_007
crossref_primary_10_1210_en_2009_1294
crossref_primary_10_1155_2016_5457010
crossref_primary_10_1002_bit_23073
crossref_primary_10_1016_j_scienta_2019_108669
crossref_primary_10_1111_j_1398_9995_2006_01135_x
crossref_primary_10_1152_ajpregu_00031_2010
crossref_primary_10_1016_j_nutres_2013_08_009
crossref_primary_10_1111_j_1525_139X_2008_00445_x
crossref_primary_10_1016_j_numecd_2010_05_007
crossref_primary_10_1159_000110446
crossref_primary_10_3390_ijms22115656
crossref_primary_10_1093_jn_137_2_351
crossref_primary_10_1080_22311866_2019_1649194
crossref_primary_10_1080_10408398_2019_1630598
crossref_primary_10_1002_mnfr_200800010
crossref_primary_10_1016_j_ctim_2021_102764
crossref_primary_10_1016_j_ejmech_2013_09_042
crossref_primary_10_1021_jf071851u
crossref_primary_10_1155_2010_153252
crossref_primary_10_1139_Y08_085
crossref_primary_10_1016_j_jff_2021_104499
crossref_primary_10_3390_antibiotics10020161
crossref_primary_10_1016_j_tetlet_2015_02_072
crossref_primary_10_1016_j_tet_2007_01_062
crossref_primary_10_1016_j_jnutbio_2007_10_006
crossref_primary_10_1016_j_colsurfb_2013_02_013
crossref_primary_10_1002_mnfr_201300318
crossref_primary_10_1016_j_exer_2016_03_024
crossref_primary_10_3390_ijms231911921
crossref_primary_10_1016_j_freeradbiomed_2017_07_019
crossref_primary_10_1002_ptr_7068
crossref_primary_10_3390_ijms241914494
crossref_primary_10_1016_j_bmc_2014_08_010
crossref_primary_10_3389_fmicb_2018_01182
crossref_primary_10_1016_j_tetasy_2017_07_004
crossref_primary_10_1111_j_1753_4887_2009_00191_x
crossref_primary_10_3390_ijms20194957
crossref_primary_10_1080_10408398_2017_1345853
Cites_doi 10.1093/jn/130.8.1887
10.1093/jn/133.5.1238
10.1016/S0021-9258(18)45614-1
10.1073/pnas.95.6.3106
10.1093/jn/133.2.399
10.1023/A:1015911519713
10.1074/jbc.M207800200
10.1161/01.CIR.0000139850.08365.EC
10.1038/35025203
10.1042/bj20020046
10.1210/er.2003-0036
10.1152/ajpcell.2001.281.5.C1442
10.1210/endo.139.10.6216
10.1016/S0735-1097(00)00590-8
10.1152/ajpcell.00334.2002
10.1194/jlr.R400001-JLR200
10.1016/j.metabol.2004.01.019
10.1016/S0891-5849(00)00235-5
10.1097/00001573-200011000-00007
10.1093/jn/134.5.1225S
10.1038/nm1102-1211
10.1093/jn/134.5.1229S
10.1093/ajcn/72.2.395
10.1006/bbrc.1994.2202
10.1016/S0006-2952(99)00409-8
10.1074/jbc.M203436200
10.1016/S0002-9343(03)00059-7
10.1016/j.bbagen.2003.12.008
10.1016/S0021-9150(02)00013-8
10.1038/nm1102-1235
10.1016/j.freeradbiomed.2003.12.012
10.1161/01.CIR.94.7.1682
10.1177/1358836X0000500108
10.1079/BJN2003820
10.1074/jbc.M005036200
10.1161/01.ATV.19.9.2094
10.1161/01.CIR.103.2.258
10.1016/S0891-5849(01)00737-7
10.1073/pnas.0408384102
10.1007/s00011-003-1182-8
10.1111/j.1749-6632.2001.tb03925.x
10.1002/biof.5520120133
10.1016/0891-5849(95)02173-6
10.1177/174182670100800402
10.1016/j.freeradbiomed.2003.08.009
10.1074/jbc.M209483200
10.1016/j.steroids.2004.05.016
10.1016/S0950-351X(98)80006-2
10.1016/S0928468002000834
10.1016/S0891-5849(00)00322-1
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
DOI 10.1152/ajpheart.00781.2004
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
DatabaseTitleList MEDLINE
CrossRef

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1522-1539
EndPage H915
ExternalDocumentID 10_1152_ajpheart_00781_2004
15805228
ajpheart_289_2_H908
Genre Research Support, U.S. Gov't, Non-P.H.S
Research Support, U.S. Gov't, P.H.S
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIAID NIH HHS
  grantid: R21 AI-054552
– fundername: NIEHS NIH HHS
  grantid: R03 ES/DK-11504
– fundername: NCCIH NIH HHS
  grantid: P50 AT-00477
GroupedDBID -
02
23M
2WC
39C
53G
5GY
5VS
8M5
ABFLS
ABPTK
ACIWK
ACPRK
ADACO
ADBBV
AENEX
AFFNX
AFRAH
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BKOMP
C1A
DIK
DL
E3Z
EBS
EJD
F5P
GX1
H13
KQ8
O0-
OK1
P2P
PQEST
PQQKQ
RAP
RHF
RHI
RPL
UKR
WH7
WOQ
---
3O-
4.4
6J9
AAFWJ
ABJNI
ACBEA
BKKCC
BTFSW
CGR
CUY
CVF
ECM
EIF
EMOBN
ITBOX
NPM
RPRKH
TR2
W8F
XSW
YSK
YYP
~02
AAYXX
CITATION
ID FETCH-LOGICAL-c393t-e44f778e1065f8438ac6d80eedd980b34a5a8720b4ad0fd3652bc9781cc6db8f3
ISSN 0363-6135
IngestDate Fri Aug 23 00:49:53 EDT 2024
Sat Nov 02 12:30:58 EDT 2024
Tue Jan 05 18:11:20 EST 2021
Mon May 06 11:35:55 EDT 2019
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c393t-e44f778e1065f8438ac6d80eedd980b34a5a8720b4ad0fd3652bc9781cc6db8f3
PMID 15805228
ParticipantIDs highwire_physiology_ajpheart_289_2_H908
crossref_primary_10_1152_ajpheart_00781_2004
pubmed_primary_15805228
PublicationCentury 2000
PublicationDate 20050801
2005-Aug
2005-08-00
PublicationDateYYYYMMDD 2005-08-01
PublicationDate_xml – month: 08
  year: 2005
  text: 20050801
  day: 01
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle American journal of physiology. Heart and circulatory physiology
PublicationTitleAlternate Am J Physiol Heart Circ Physiol
PublicationYear 2005
References R21
R20
R23
R22
R25
R24
R27
R26
R29
R28
R1
R2
R3
R4
R5
R6
R7
R8
R9
R30
R32
R31
R34
R33
R36
R35
R38
R37
R39
R41
R40
R43
R42
R45
R44
R47
R46
R49
R48
R50
R10
R12
R11
R14
R13
R16
R15
R18
R17
R19
References_xml – ident: R49
  doi: 10.1093/jn/130.8.1887
– ident: R28
  doi: 10.1093/jn/133.5.1238
– ident: R1
  doi: 10.1016/S0021-9258(18)45614-1
– ident: R42
  doi: 10.1073/pnas.95.6.3106
– ident: R50
  doi: 10.1093/jn/133.2.399
– ident: R31
  doi: 10.1023/A:1015911519713
– ident: R29
  doi: 10.1074/jbc.M207800200
– ident: R26
  doi: 10.1161/01.CIR.0000139850.08365.EC
– ident: R27
  doi: 10.1038/35025203
– ident: R6
  doi: 10.1042/bj20020046
– ident: R22
  doi: 10.1210/er.2003-0036
– ident: R21
  doi: 10.1152/ajpcell.2001.281.5.C1442
– ident: R23
  doi: 10.1210/endo.139.10.6216
– ident: R25
  doi: 10.1016/S0735-1097(00)00590-8
– ident: R20
  doi: 10.1152/ajpcell.00334.2002
– ident: R30
  doi: 10.1194/jlr.R400001-JLR200
– ident: R48
  doi: 10.1016/j.metabol.2004.01.019
– ident: R33
  doi: 10.1016/S0891-5849(00)00235-5
– ident: R14
  doi: 10.1097/00001573-200011000-00007
– ident: R2
  doi: 10.1093/jn/134.5.1225S
– ident: R39
  doi: 10.1038/nm1102-1211
– ident: R12
  doi: 10.1093/jn/134.5.1229S
– ident: R47
  doi: 10.1093/ajcn/72.2.395
– ident: R40
  doi: 10.1006/bbrc.1994.2202
– ident: R41
  doi: 10.1016/S0006-2952(99)00409-8
– ident: R46
  doi: 10.1074/jbc.M203436200
– ident: R37
  doi: 10.1016/S0002-9343(03)00059-7
– ident: R35
  doi: 10.1016/j.bbagen.2003.12.008
– ident: R38
  doi: 10.1016/S0021-9150(02)00013-8
– ident: R24
  doi: 10.1038/nm1102-1235
– ident: R34
  doi: 10.1016/j.freeradbiomed.2003.12.012
– ident: R43
  doi: 10.1161/01.CIR.94.7.1682
– ident: R8
  doi: 10.1177/1358836X0000500108
– ident: R15
  doi: 10.1079/BJN2003820
– ident: R16
  doi: 10.1074/jbc.M005036200
– ident: R18
  doi: 10.1161/01.ATV.19.9.2094
– ident: R45
  doi: 10.1161/01.CIR.103.2.258
– ident: R32
  doi: 10.1016/S0891-5849(01)00737-7
– ident: R36
  doi: 10.1073/pnas.0408384102
– ident: R44
  doi: 10.1007/s00011-003-1182-8
– ident: R10
  doi: 10.1111/j.1749-6632.2001.tb03925.x
– ident: R3
  doi: 10.1002/biof.5520120133
– ident: R4
  doi: 10.1016/0891-5849(95)02173-6
– ident: R11
  doi: 10.1177/174182670100800402
– ident: R5
  doi: 10.1016/j.freeradbiomed.2003.08.009
– ident: R9
  doi: 10.1074/jbc.M209483200
– ident: R13
  doi: 10.1016/j.steroids.2004.05.016
– ident: R7
  doi: 10.1016/S0950-351X(98)80006-2
– ident: R19
  doi: 10.1016/S0928468002000834
– ident: R17
  doi: 10.1016/S0891-5849(00)00322-1
SSID ssj0005763
Score 2.1844742
Snippet Departments of 1 Pathology, 2 Pharmacology, and 3 Anesthesiology, 4 Purdue-University of Alabama at Birmingham Botanical Center for Age-Related Disease, and 5...
The antiatherogenic effects of soy isoflavone consumption have been demonstrated in a variety of studies. However, the mechanisms involved remain poorly...
SourceID crossref
pubmed
highwire
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage H908
SubjectTerms Anti-Inflammatory Agents - pharmacology
Aorta
Cell Adhesion - drug effects
Cell Adhesion Molecules - metabolism
Cell Communication - drug effects
Cells, Cultured
Endothelial Cells - physiology
Genistein - pharmacology
Glycine max - chemistry
Humans
Isoflavones - pharmacology
Leukocytes - physiology
Monocytes - physiology
Phosphorylation
PPAR gamma - physiology
Reactive Oxygen Species - metabolism
Receptors, Estrogen - metabolism
Stress, Mechanical
Tumor Necrosis Factor-alpha - pharmacology
Tyrosine - metabolism
Title Revealing anti-inflammatory mechanisms of soy isoflavones by flow: modulation of leukocyte-endothelial cell interactions
URI http://ajpheart.physiology.org/cgi/content/abstract/289/2/H908
https://www.ncbi.nlm.nih.gov/pubmed/15805228
Volume 289
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfKkBAvCDY-ypf8gOChpGRx0ia8TQhUUQ0B6qS9RfFHtK5NUrXpIPy9_CHcxUnsbRVivERVYluX3i_23fnuZ0JeJUqMkmisHOFj6CZVhw5nCXgpQjCJ_FJ-Hcw5_jKanPifT4PTXu-3lbW0LflQ_NpZV_I_WoV7oFeskr2BZrtB4Qb8Bv3CFTQM13_S8Xd1AXaeLjMs5w4MCfrN9L55prCmd77J6lyNTVEN5psCnl8gOT8anemy-IHxgKyQzRFe2HCptotCVKVyVC6xOmuJIXUM79fMEmtdB7Gxbdpu08dioagDJnXEfoiVTmudxy7ma0x7reUzLawMA7Eo9CbIcjuYDq0HSAVhZYIPZkODlFyeqYXOEwdRqm6dmZ4VRQN2dOAvBziCLr3OFHYx8HA1q8lQNfM0-NAwWUf2RO7pw4gaxHrWtDyJ3NBa4ieRLiG9vnwESEebnK_wNPESadVDHUMwq2WbIXBlEe1SG2unKvDidpC4HgRP-_RvkdseTIc4D0-_GU578PhYu6OOr9lwY8Eg73ZIctl-ajmtrzhFtXE0u0_uNV4NPdIQfUB6Kt8nB0c5qDqr6Gv6tVP2Prlz3KRzHJCfHYDpNQBTA2BapBQATC0AU15RBPB7auCLzXbClyJ8qQ3fh-Tk08fZh4nTHAXiCBax0lG-n47HoToEizkNfRYmYiRDFww8GYUuZ34SJOHYc7mfSDeVbBR4XCCdm4B2PEzZI7KXg3hPCAUHPgWbVnrS5-DuMy7cgCvo4krOAyX75G37B8crzfgS_0WpfcJaJcTmy4kxgDQDZHRdAJyxFyMQ45VM--TNrl7d-KZ1nzzWmjXCBHgMiRc-vZmgz8hd83U9J3vleqtegEFd8pc1Hv8A_ETXMg
link.rule.ids 315,783,787,27936,27937
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Revealing+anti-inflammatory+mechanisms+of+soy+isoflavones+by+flow%3A+modulation+of+leukocyte-endothelial+cell+interactions&rft.jtitle=American+journal+of+physiology.+Heart+and+circulatory+physiology&rft.au=Chacko%2C+Balu+K.&rft.au=Chandler%2C+Robert+T.&rft.au=Mundhekar%2C+Ameya&rft.au=Khoo%2C+Nicholas&rft.date=2005-08-01&rft.issn=0363-6135&rft.eissn=1522-1539&rft.volume=289&rft.issue=2&rft.spage=H908&rft.epage=H915&rft_id=info:doi/10.1152%2Fajpheart.00781.2004&rft.externalDBID=n%2Fa&rft.externalDocID=10_1152_ajpheart_00781_2004
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0363-6135&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0363-6135&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0363-6135&client=summon